MINNEAPOLIS, Mn. (CNN) - It's being called a breakthrough for migraine suffers.
A new FDA approved treatment called Emgality is the third in a class of new drugs that aim to stop the headaches before they begin.
It's a once a month treatment. Medical professionals say Emgality binds with a substance of the brain that may cause migraines. They say there’s no major side effects
One of the drug researchers is Minneapolis based headache specialist Dr. Gary Berman.
Dr. Berman says 50-60 percent of patients get a 50 percent reduction in migraines each month.
The drug costs about $575 dollars a month.
The company Lily is offering some sufferers their first year of doses for free.
- Migraine treatment aimed to stop pain before it starts
- FDA approves preventive migraine treatment
- Natural treatment helps pets not be "stuck" with pain
- Indiana officials aim to expand drug treatment programs
- #ThinkBeforeYouPost, campaign aimed at stopping hoax threats
- Pain medication missing at eastern Indiana prison
- Fed approve HIP work requirement, drug treatment
- New treatment program to fight opioid abuse
- New treatment approved for drug-resistant tuberculosis
- New shingles shot offers more protection against painful disease